InMed Pharmaceuticals Inc. (INM)
Nov 6, 2026 - INM was delisted (reason: merged into MTRI)
15.56
+2.35 (17.79%)
Inactive · Last trade price on Nov 6, 2026
InMed Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
10.34M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | - | - | - |
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 4.60M | 462.17K | 11.18% |
| Jun 30, 2023 | 4.14M | 3.05M | 279.61% |
| Jun 30, 2022 | 1.09M | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
INM News
- 5 days ago - 3 Stocks with More Than 40% Upside and Recent Buy Ratings from Analysts - TipRanks
- 8 days ago - InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics - PRNewsWire
- 9 days ago - InMed expects to start trading as Mentari Therapeutics on November 9 - TheFly
- 9 days ago - InMed Announces Expected Closing of Merger and Commencement of Trading on Nasdaq Under the Name "Mentari Therapeutics, Inc." and Ticker Symbol "MTRI" - Newsfile Corp
- 10 days ago - InMed Pharmaceuticals Inc trading resumes - TheFly
- 10 days ago - InMed Pharmaceuticals Inc trading halted, volatility trading pause - TheFly
- 10 days ago - InMed Pharmaceuticals Inc trading halted, news pending - TheFly
- 10 days ago - InMed Announces Results of 2026 Annual General and Special Meeting, Approval of Corporate Name Change and Completion of Share Consolidation - Newsfile Corp